-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Market Perform on Accendra Health, Lowers Price Target to $2.75

Benzinga·02/20/2026 21:44:22
Listen to the news
Leerink Partners analyst Michael Cherny maintains Accendra Health (NYSE:ACH) with a Market Perform and lowers the price target from $3 to $2.75.